These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16801575)

  • 1. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance.
    Maddux BA; Chan A; De Filippis EA; Mandarino LJ; Goldfine ID
    Diabetes Care; 2006 Jul; 29(7):1535-7. PubMed ID: 16801575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance.
    Borai A; Livingstone C; Zarif H; Ferns G
    Ann Clin Biochem; 2009 Mar; 46(Pt 2):109-13. PubMed ID: 19164337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
    Ricart W; Fernández-Real JM
    Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK; Jain SK
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the insulin-like growth factor axis response to a glucose load.
    Flanagan DE; Holt RI; Owens PC; Cockington RJ; Moore VM; Robinson JS; Godsland IF; Phillips DI
    Acta Physiol (Oxf); 2006 Jul; 187(3):371-8. PubMed ID: 16776662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of a [13C]glucose breath test with surrogate markers of insulin resistance in urban and rural Asian Indians.
    Banerjee D; Vikram N; Mishra P; Bhatt R; Prakash S; Misra A
    Metab Syndr Relat Disord; 2009 Jun; 7(3):215-9. PubMed ID: 19284316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance.
    Borai A; Livingstone C; Mehta S; Zarif H; Abdelaal F; Ferns G
    Clin Biochem; 2009 Aug; 42(12):1270-4. PubMed ID: 19463807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
    Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.
    Kamoda T; Nozue H; Matsui A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):290-4. PubMed ID: 17224001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.
    Arafat AM; Weickert MO; Frystyk J; Spranger J; Schöfl C; Möhlig M; Pfeiffer AF
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5093-101. PubMed ID: 19846739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
    Inoue M; Yano M; Yamakado M; Maehata E; Suzuki S
    Metabolism; 2006 Sep; 55(9):1248-54. PubMed ID: 16919546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study.
    Lewis JG; Shand BI; Frampton CM; Elder PA; Scott RS
    Clin Biochem; 2008 Sep; 41(13):1034-8. PubMed ID: 18588869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.